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Purpose: To present the clinical, imaging, pathological and immunohistochemical features of giant cell
angiofibroma (GCA).
Case presentation: In this paper we report an atypical case of a GCA extending from the parotid to the
parapharyngeal space. The lesion was being treated as a vascular malformation for one year prior to surgical
removal. We summarize the clinical manifestations, imaging, pathological and molecular features of this rare
disease.
After complete surgical removal of the tumor, immunohistochemical analysis revealed strong positivity for the
mesenchymal markers vimentin, CD34, CD31 and CD99 in neoplastic cells. Tumor proliferation antigen marker Ki67
was partly positive (<5% of cells). Tumor cells were negative for muscle-specific actin, epithelial membrane antigen,
smooth muscle actin, cytokeratin pan, S100, desmin, glial fibrillary acidic protein, myogenin, MyoD1 and F8. The
morphological and immunohistochemical profile was consistent with the diagnosis of GCA.
Conclusion: GCA is a rare soft tissue tumor that can easily be misdiagnosed in the clinical preoperative setting. In
view of the clinical, pathological and molecular features of the tumor, complete surgical removal is the current
optimal treatment option, providing accurate diagnosis and low to minimal recurrence rate.
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Giant cell angiofibroma (GCA) was first described by
Dei Tos as a rare soft tissue tumor of the orbit [1]. Since
the initial report of the disease in orbital tissue, GCA
has been reported in a variety of other extraorbital sites
[2-8]. GCA is a benign, mesenchymal lesion showing
histological features intermediate between, but distinct
from, solitary fibrous tumor (SFT) and giant cell fibro-
blastoma (GCF) of soft tissue [5].
In this paper, we report a rare case of a patient with a
large GCA extending from the right parotid gland to the
homolateral parapharyngeal space that was being treated* Correspondence: wyuehe@gmail.com
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unless otherwise stated.as a vascular malformation for a year prior to surgical
removal. The clinical findings, diagnostic procedure
followed, treatment and histopathological/immunohisto-
chemical findings are also outlined in this paper.Case presentation
Clinical examination
A 29-year-old male was referred to our outpatient de-
partment with a 24-month history of a slowly growing,
painless mass of the right parotid gland and subman-
dibular region. He also complained of mild discomfort
during swallowing. The patient’s medical history was
unremarkable with no previous history of surgery. At
the time, he was diagnosed as having a vascular mal-
formation of the right parotid-parapharyngeal region
and he had been under treatment for one year withThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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stabilization of the tumor.
Extraoral physical examination at the time of referral
was suggestive of a large, mobile, smooth-surfaced, fibroe-
lastic soft tissue mass, which was palpated in the lower
pole of the right parotid gland. The lesion extended sub-
cutaneously along the homolateral submandibular and
pharyngeal spaces (Figure 1A). On palpation the mass was
painless with no evidence of any emanating pulsation.
Neurological examination of cranial nerves was normal,
and no palpable lymph nodes were present in the neck,
supraclavicular or axillary regions.
Upon intraoral examination, there was evidence of the
mass bulging to the right oral pharynx with subsequent
obliteration of the palatoglossal arch. Deviation of the
uvula and soft palate was not evident during opening of
the mouth. Covering mucosa of the region was normal
in color and texture (Figure 1B). The remainder of the
head and neck clinical examination was normal.
Diagnostic tests
The patient was initially clinically diagnosed with a vas-
cular malformation (VM) of the parotid, submandibular
and parapharyngeal spaces based on computed tomo-
graphy (CT) scan, magnetic resonance imaging (MRI) ofFigure 1 Clinical view of the tumor. (A) Preoperative extraoral clinical vie
(C) Postoperative extraoral clinical view of the patient. (D) Postoperative inthe head and neck and a fine needle aspiration biopsy
that was indicative of intense hemorrhagic necrosis. At
the time, the mass measured approximately 58 × 25 ×
47 mm (Figure 2A, B). After unsuccessful treatment with
sclerotherapy for one year, a new MRI was performed
revealing slow growth of the tumor. MRI was suggestive
of an inhomogeneous mass which measured 81 × 34 ×
67 mm and extended from the right parotid gland into
the right parapharyngeal space. (Figure 2C, D). The
signal of the mass was isointense to the circumambient
soft tissue in T1W1. Hyperintense signal was demon-
strated in T2W1 and T2W1 (Fat suppression) images.
There was no sign of infiltration to adjacent soft tissue
and no bone erosion was identified on imaging studies.
MRI findings were suggestive of a benign parotid gland
tumor with involvement of the homolateral subman-
dibular and parapharyngeal spaces.
Treatment
As mentioned above, clinical history and physical exa-
mination were suggestive initially of the diagnosis of
VM. Thus, the patient was first treated with a regimen
of percutaneous sclerotherapy using ethanol and lauro-
macrogol for a period of one year without any complica-
tions. During this period, no response to sclerotherapyw of the patient. (B) Preoperative intraoral view of the patient.
traoral clinical view of the patient.
Figure 2 Giant cell angiofibroma. (A) Axial T1-weighted MRI of the tumor prior to sclerotherapy. (B) Coronal T1-weighted MRI of the tumor
prior to sclerotherapy. (C) Preoperative axial T2-weighted MRI of the tumor after sclerotherapy. (D) Preoperative coronal T1-weighted MRI of the
tumor after sclerotherapy. (E) Postoperative axial T1-weighted MRI at six months after resection showing no signs of recurrence. (F) Postoperative
coronal T1-weighted MRI at six months after resection showing no signs of recurrence.
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size with no other significant changes in regard to its
clinical and radiological consistency.
Since sclerotherapy treatment proved unsuccessful,
after discussion and written consent from the patient
the decision to surgically remove the tumor was made.
The patient was prepared for general anesthesia via
nasotracheal intubation. Access to the tumor was fea-
sible through a preauricular incision with a submandi-
bular extension. A skin flap above the parotid fascia and
incorporating the platysma muscle was raised with sub-
sequent identification and preservation of the cervicofa-
cial branch of the facial nerve. The tumor appeared to
have no obvious infiltration to the surrounding tissues
and was excised completely. There was no major intra-
operative bleeding. The residual surgical defect was not
reconstructed and the wound was closed in layers under
suction drainage.
Macroscopically, the tumor was shaped like a dumb-
bell and contained a single cystic space filled with a
yellow-brown sticky fluid.
The patient’s postoperative healing was uneventful. He
is on a regular follow up program and six months post-
operatively there is no sign of recurrence (Figure 1C, D,
Figure 2E, F).
Histopathology
Light microscopy examination of the lesion showed in-
creased cellularity, with spindled and elongated cellsintermingled with variable amounts of capillary-sized
blood vessels, pseudovascular spaces, and floret-like
multinucleated giant cells (Figure 3). At high magni-
fication, the spindle-shaped tumor cells had plump nu-
clei and pale eosinophilic cytoplasm. No mitoses were
identified.
Immunohistochemistry was performed and the mesen-
chymal markers vimentin, CD31, CD34, CD99 were
positive in spindle cells and giant cells. Tumor prolifera-
tion antigen marker Ki67 was partly positive (<5% of
cells). Muscle-specific actin (MSA), epithelial membrane
antigen (EMA), smooth muscle actin (SMA), cytokeratin
pan (CKP), S100, desmin, CD31, glial fibrillary acidic
protein (GFAP), myogenin, MyoD1 and F8 were negative
(Figure 4). The morphology and immunohistochemical
profile were consistent with the diagnosis of GCA.
Discussion
GCA is a rare tumor of soft tissues. Although it was
firstly described as a distinct orbital neoplasm by Dei
Tos [1], until now there are approximately 26 various
extraorbital site cases reported in the literature [2-18]
(Table 1). By taking into account the orbital GCA cases
and extraorbital head and neck cases we could assume
that GCA may have a predilection for the head and neck
region.
The tumor may grow rapidly, simulating malignancy,
or may have an indolent course with slow growth over
many years. GCA most often occurs in middle-aged
Figure 3 Histopathological examination. (A) and (B) Microscopic examination revealed a circumscribed, richly vascularized, patternless spindle
cell proliferation containing pseudovascular spaces and floret-like multinucleated giant cells (arrow), sometimes lining the pseudovascular spaces,
in a variably collagenous or myxoid stroma. (H&Ex400).
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tion of this tumor, some reports suggest that orbital
GCA is more common in men, while extraorbital loca-
tions are more common in women [6].
Gonzalez-Perez et al. were the first to report a GCA
of the parapharyngeal region in a 25-year-old female pa-
tient [6]. Both GCA cases presented with similar clinical
characteristics of a benign non-infiltrative slow growing
tumor. In both cases a differential diagnosis of parotid
gland, fibrous or vascular tumor was made. In our case,
the more cystic (pseudocystic) nature of the tumor in
addition to the lack of other evidence from the fine nee-
dle aspiration biopsy, led to the misdiagnosis of the
tumor as a VM. Despite the positive results for CD31 in
our case, histological and immunohistochemical findings
were also similar in both cases.Figure 4 Immunohistochemical analysis revealed strong positivity for
(D) CD99.The pathogenesis of the tumor remains unclear. There
are currently two papers in the literature trying to asso-
ciate an orbital case of GCA with mutations on chro-
mosome 6q13 [18] and another extraorbital case with an
associated translocation t(12;17) [14].
In the clinical setting during preoperative manage-
ment, diagnosis of GCA may be virtually impossible. Be-
sides the fact that GCA is an extremely rare tumor it
also shares many clinical and radiological features with
other soft tissue tumors of the head and neck. Further-
more the pseudovascular spaces that are present in large
GCAs may associate it with tumors of vascular origin, as
in our case. The multitude of soft tissue tumors of the
region that need to be differentially diagnosed from
GCA, can be roughly depicted in an abbreviated sum-
mary of the World Health Organization (WHO) systemthe mesenchymal markers. (A) Vimentin. (B) CD34. (C) CD31.
Table 1 Known reported giant cell angiofibroma
extraorbital cases
Head and neck area Other anatomic areas
Subcutaneous neck area 1 Cutaneous (thigh) 1
Occipital region 2 Hip 1
Retroauricular area 1 Forearm 1
Parotid 1 Vulva 1
Submandibular region 1 Retroperitoneum 1
Parapharyngeal space 1 Back 3
Oral buccal mucosa 3 Mediastinum 1
Tongue 1 Axilla 1
Vocal cord 2 Groin/Inguinal region 3
Source: References [2-18].
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type and biologic potential (Table 2) [19].
Vascular malformation is a collective term for many dif-
ferent disorders of the vasculature. It can be a disorder of
capillaries, arteries, veins and lymphatics or a combination
of those. A VM consists of a clew of deformed vessels, due
to an error in vascular development. However, endothelial
turnover is stable in these defects. Congenital VMs are
always present at birth, although they are not always
visible. In contrast to vascular tumors, vascular malforma-
tions do not have a growth phase, nor an involution phase,
they tend to grow proportionately with the child, never
regressing and persisting throughout life [20]. VascularTable 2 Summary of World Health Organization (WHO) classif
Histologic type Benign Intermediate,
locally aggressive
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Source- Reference [19].malformations can be divided in slow-flow VM, fast-flow
VM and complex-combined VM. Clinically, diagnosis of
superficial VM is not difficult, deep VM should be
determined by clinical examination with identification of
postural movement and a positive puncture test. Ultra-
sound and MRI can aid significantly in the diagnosis of
VM, while angiography is usually reserved for treatment
planning.
In our case, the patient had a slow growing tumor in
the head and neck region over a period of more than
two years. MRI findings were suggestive of a benign
non-infiltrating tumor with heterogeneous signal inten-
sity extending from the parotid to the parapharyngeal
space which demonstrated intense enhancement after
the administration of contrast material. Overall, the
cystic nature of the tumor in conjunction with excess
blood material in the fine needle aspirate led to the mis-
diagnosis of this GCA case as a vascular malformation.
Sclerotherapy, as expected, had no effect on the lesion
which in fact continued to slowly grow. Final diagnosis
was only feasible after referral of the patient for surgical
removal and subsequent histopathological and immuno-
histochemical testing of the tumor.
GCA is typically regarded as a non-invasive neoplasm
with no potential for metastatic disease compared to
solitary fibrous tumor which may rarely metastasize [19].
There is controversy regarding the potential of the
tumor for recurrence. Since there have not been enough
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surgical removal and long-term follow up was con-
sidered the optimal treatment option.
Diagnosis of GCA is usually made after resection and
immunohistochemical analysis. Histological characte-
ristics of GCA include: (1) the presence of homogenous
irregularly organized proliferating cells that are round or
oval shaped (2) the stromal region that is often collage-
nized or myxoid and (3) the tumor is richly vascularized
and contains pseudovascular spaces in the presence of
interstitial hemorrhage. The pseudovascular spaces are
lined with multinucleated giant cells [11].
The immunohistochemical features of GCA include
positive staining for CD34, CD99, vimentin, variable bcl2
and negative staining for CD31, CD68, c-kit/CD117,
muscle specific actin, S100, desmin [7,21].
In our case, positive staining for CD34 in combination
with the presence of giant cells and pseudovascular
spaces confirmed the diagnosis of GCA. A controversial
finding was the unexpected positivity of CD31 in the
majority of cells compared to previous reports [7,21].
Clinically, this immunohistochemical finding may be
interpreted by the more vascular nature of the tumor
and it may provide a tool for differential diagnosis of
GCA from SFT in the future. Nevertheless several other
soft tissue tumors may present with similar findings. For
example, GCA might be closely related to GCF, multinu-
cleate cell angiohistiocytoma (MCA), SFT and VM.
GCF is usually differentially diagnosed from GCA by
the fact that it is usually a poorly circumscribed lesion
invading the dermis and subcutis of somatic soft tissues.
The tumor, which typically occurs within the first de-
cades of life, is rarely described in middle-aged and older
patients. It most commonly affects the trunk [22].
Although GCF is composed of CD34 positive spindle
and stellate shaped cells including multinucleated floret-
like giant cells and tumor cell-lined pseudovascular
spaces, it has infiltrative margins and has less conspi-
cuous cellularity and vasculature. Clinically, GCF ap-
pears to be a more aggressive lesion than GCA in that
up to 50% of cases locally recur [3].
MCA is a rare benign proliferation of the skin of un-
known etiology. Clinically, MCA shows a predilection
for adult women (F:M ratio 3:1) and manifests as a sin-
gle or multiple firm, red-brown or violaceous papules
with a smooth, or occasionally, scaly surface [23]. Histo-
logical examination shows a vascular proliferation pre-
dominantly of capillaries and veins in the upper and mid
dermis with lymphohistiocyte infiltration. Multinucleate
giant cells are arranged in a ring-like or overlapping pat-
tern, with a positive staining for factor XIIIa [24].
The CD34-positive cell neoplasm most closely aligned
to GCA is the SFT, which was first described in the pleura
but has since been reported in many locations. Inapproximately half of all described cases it is located in
the subcutaneous tissue, but also in deep soft tissue of the
extremities, or in the head and neck region, the thoracic
wall, mediastinum and abdominal cavity. SFTs on CT
scans show moderate to intense enhancement in a well
circumscribed mass. Histologically, SFTs show a pat-
ternless spindle cell proliferation in a collagenous stroma,
although myxoid areas are not uncommon, and a heman-
giopericytomatous vascular pattern that is not seen in
GCA. Giant cells and pseudovascular spaces are infre-
quent and serve to distinguish this tumor type from GCA.
Both are immunoreactive for CD34 and CD99 [16,25,26].
There is a lot of debate in the literature concerning the
classification of GCA. Although many authors believe
GCA to be a distinct tumor with distinct histological and
immunohistochemical characteristics, others support the
opinion that this may be a variant of either SFT or GCA.
In fact, the idea that GCA may be a variant of SFT is fur-
ther supported by WHO’s latest reclassification (2013)
[27], where GCA is considered a synonym for extrapleural
SFT rather than being a separate entity. In this reclassifi-
cation GCA, SFT, hemangiopericytoma and lipomatous
hemangiopericytoma are all interconnected and are in-
cluded under the same category of ‘extrapleural SFT’.
Conclusion
In conclusion, GCA is a rare benign tumor which mainly
affects soft tissue(s) in the head and neck area. Clinical
or radiological diagnosis alone is very difficult since
clinical characteristics and radiological features of the
tumor resemble those of many other benign soft tissue
tumors. In particular, for cases resembling vascular mal-
formations as in our report, clinicians should be aware
of this entity to avoid unnecessary delay and treatment.
Surgery is the main treatment. Microscopic examination
and immunohistochemical analysis provide the only
means of diagnosis mainly by identification of giant cells
and pseudovascular spaces in conjunction with positivity
for vimentin and CD34. Classification of GCA is still
under question in our opinion. Further reports and stu-
dies of this tumor are needed to define the pathophy-
siology and understanding of the tumor.
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